UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.972-982

2019

Link zum Volltext

Verfügbarkeit prüfen

Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

Arthritis & rheumatology (Hoboken, N.J.), 2022-06, Vol.74 (6), p.1039-1047

2022

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Arthritis & rheumatology (Hoboken, N.J.), 2017-07, Vol.69 (7), p.1451-1460

2017

Link zum Volltext

Verfügbarkeit prüfen

CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2018-10, Vol.70 (10), p.1644-1653

2018

Link zum Volltext

Verfügbarkeit prüfen

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2021-12, Vol.73 (12), p.2338-2347

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2021-07, Vol.73 (7), p.1277-1287

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Annals of the rheumatic diseases, 2021-02, Vol.80 (2), p.143

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum markers of cardiac complications in a systemic sclerosis cohort

Scientific reports, 2022-03, Vol.12 (1), p.4661-4661, Article 4661

2022

Link zum Volltext

Verfügbarkeit prüfen

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

American journal of respiratory and critical care medicine, 2019-11, Vol.200 (10), p.1258-1266

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-08, Vol.67 (8), p.2205-2212

2015

Link zum Volltext

Verfügbarkeit prüfen

Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis

Current opinion in rheumatology, 2016-11, Vol.28 (6), p.613-618

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey

Advances in therapy, 2021-02, Vol.38 (2), p.854-867

2021

Link zum Volltext

Verfügbarkeit prüfen

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease

Respiratory research, 2020-07, Vol.21 (1), p.1-197, Article 197

2020

Link zum Volltext

Verfügbarkeit prüfen

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

PloS one, 2020-05, Vol.15 (5), p.e0232739-e0232739

2020

Link zum Volltext

Verfügbarkeit prüfen

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort

Rheumatology (Oxford, England), 2020-10, Vol.59 (10), p.2920-2929

2020

Link zum Volltext

Verfügbarkeit prüfen

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis

Chest, 2016-08, Vol.150 (2), p.299-306

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease

Journal of rheumatology, 2015-01, Vol.42 (1), p.60

2015

Link zum Volltext

Verfügbarkeit prüfen

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-163, Article 163

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases

Arthritis research & therapy, 2021-08, Vol.23 (1), p.1-212, Article 212

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2017-11, Vol.69 (11), p.2209-2221

2017

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches

Journal of scleroderma and related disorders, 2021-02, Vol.6 (1), p.37-43

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

Swiss medical weekly, 2024-02, Vol.154, p.3630

2024

Link zum Volltext

Verfügbarkeit prüfen

Neue Wege in der Therapie der SSc-ILD: Was macht Sinn?

Zeitschrift für Rheumatologie, 2019-11, Vol.78 (9), p.863-864

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)

Zeitschrift für Rheumatologie, 2021-10, Vol.80 (8), p.743-754

2021

Link zum Volltext

Verfügbarkeit prüfen

Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis

PloS one, 2018, Vol.13 (11), p.e0206545-e0206545

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(118)
Norwegisch
(16)
Japanisch
(13)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(77)
Rheumatology
(64)
Humans
(61)
Systemic Sclerosis
(47)
Scleroderma
(36)
Female
(29)
Male
(27)
Scleroderma, Systemic - Complications
(27)
Middle Aged
(24)
Lung Diseases
(21)
Patients
(19)
Interstitial Lung Disease
(18)
Lung Diseases, Interstitial - Etiology
(18)
Adult
(17)
Autoimmune Diseases
(16)
Mortality
(16)
Disease Progression
(15)
Immunology
(14)
Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Serum markers of cardiac complications in a systemic sclerosis cohort

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis

Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis

Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort

The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort

Neue Wege in der Therapie der SSc-ILD: Was macht Sinn?

Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)

Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis

Suchergebnisse filtern